Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 26-Jun-24 4:26 PM View:  | Alnylam Pharmaceuticals Inc. (ALNY) | 25-Jun-24 | Sale | 1,605 | $230.99 | $370,747.00 | (12%) 13.27K to 11.66K | |
| 26-Jun-24 4:26 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 24-Jun-24 | Grant | 3,278 | -- | -- | 33% 9.99K to 13.27K | |
| 05-Mar-24 4:22 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 01-Mar-24 | Grant | 4,751 | -- | -- | 91% 5.24K to 9.99K | |
| 29-Feb-24 4:18 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 28-Feb-24 | Option Sale | 501 | $155.30 | $77,805.40 | (9%) 5.74K to 5.24K | |
| 29-Feb-24 4:18 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 27-Feb-24 | Option Exercise | 1,667 | -- | -- | 41% 4.07K to 5.74K | |
| 20-Feb-24 4:08 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 16-Feb-24 | Sale | 1,009 | $148.06 | $149,397.00 | (20%) 5.08K to 4.07K | |
| 20-Feb-24 4:08 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 15-Feb-24 | Grant | 3,278 | -- | -- | 182% 1.8K to 5.08K | |
| 28-Apr-23 5:55 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 27-Apr-23 | Sale | 1,476 | $194.59 | $287,215.00 | (45%) 3.28K to 1.8K | |
| 28-Apr-23 5:55 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 26-Apr-23 | Grant | 3,277 | -- | -- | 100% 0 to 3.28K | |
| 03-Feb-23 5:45 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 03-Feb-23 | Planned Option Sale | 3,424 | $232.14 | $794,854.00 | (100%) 3.42K to 0 | |
| 03-Feb-23 5:45 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 02-Feb-23 | Option Sale | 1,601 | $226.01 | $361,839.00 | (32%) 5.03K to 3.42K | |
| 03-Feb-23 5:45 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 01-Feb-23 | Option Exercise | 5,025 | -- | -- | 100% 0 to 5.03K | |
| 05-Aug-22 4:15 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 05-Aug-22 | Sale (Planned) | 1,841 | $218.16 | $401,630.00 | (100%) 1.84K to 0 | |
| 05-Aug-22 4:15 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 04-Aug-22 | Payment of Exercise | 1,788 | $191.73 | $342,817.00 | (49%) 3.63K to 1.84K | |
| 05-Aug-22 4:15 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 03-Aug-22 | Grant | 3,629 | -- | -- | 207% 1.75K to 5.38K | |
| 05-Aug-22 4:15 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 03-Aug-22 | Sale (Planned) | 1,754 | $210.00 | $368,340.00 | (33%) 5.38K to 3.63K | |
| 07-Jul-22 4:06 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 05-Jul-22 | Market Sale (Planned) | 1,754 | $150.00 | $263,100.00 | (50%) 3.51K to 1.75K | (< 1%) |
| 03-Feb-22 4:10 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 02-Feb-22 | Payment of Exercise | 1,518 | $144.67 | $219,609.00 | (30%) 5.03K to 3.51K | |
| 03-Feb-22 4:10 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 01-Feb-22 | Option Exercise | 5,026 | -- | -- | 100% 0 to 5.03K |